Find out what’s new and what’s next in treatment options for DMD.
-
-
Looking back: The advice I’d give my younger self
-
FDA advisory panel votes against deramiocel for DMD-related heart disease
-
FDA agrees to review application for DYNE-251 DMD therapy
-
As life expectancy grows, more adults with DMD are not only surviving, but thriving
-
More Duchenne travel tips: Preparing for everything beyond the flight
-
DMD drugs Amondys 45 and Vyondys 53 head to the FDA for full approval review